CLARAVA

WIPO WIPO 2021

Protect this trademark from copycats!

With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.

The International trademark CLARAVA was filed as Word mark on 09/03/2021 at the World Intellectual Property Organization.

Trademark Details Last update: July 18, 2023

Trademark form Word mark
File reference 1621013
Countries Australia Brazil Canada Switzerland China em United Kingdom Israel India Japan South Korea Mexico Norway New Zealand Russia Singapore
Base trademark US No. 90563233, March 5, 2021
Application date September 3, 2021
Expiration date September 3, 2031

Trademark owner

Avon House, 19 Stanwell Road
Panarth, Cardiff CF642EZ
GB

Trademark representatives

1299 Pennsylvania Avenue, NW, Suite 700 US

goods and services

05 Medical diagnostic blood or biopsy testing reagents and assays for advanced next-generation sequencing science for creating immune profiling of kidney transplant recipients for predicting and identifying risk of graft rejection; medical diagnostic reagents consisting primarily of reagents for use in disease testing and prediction; nucleic acid sequences and chemical reagents for medical purposes
10 Blood test collection kit comprised of blood collection tube and bag, and holder for medical sample tubes, for predicting and identifying the risk of graft injury and graft loss in kidney transplant recipients
42 Development of new technology for others in the field of medical devices and medical diagnostic apparatuses; research, development and consultation related thereto in the field of medical devices and medical diagnostic apparatuses through the use of artificial intelligence; laboratory research in the field of kidney transplant; medical research services; computer software development; providing temporary use of on-line non-downloadable software and software applications using artificial intelligence for medical analysis
44 Medical profile and medical record analysis designed to provide patients with custom tailored information about the range of possible diagnoses and therapies associated with a defined set of symptoms; medical analysis services for predicting and identifying risk of graft rejection in kidney transplant patients

Trademark history

Date Document number Area Entry
July 13, 2023 2023/29 Gaz KR RAW: Rule 18ter(2)(ii) GP following a provisional refusal
February 28, 2023 2023/11 Gaz CN RAW: Rule 18ter(2)(ii) GP following a provisional refusal
January 30, 2023 2023/5 Gaz CA Rejection
December 6, 2022 2022/49 Gaz KR Rejection
October 26, 2022 2022/43 Gaz BR Rejection
September 26, 2022 2022/39 Gaz IN Rejection
September 23, 2022 2022/38 Gaz NO Rejection
September 1, 2022 2022/35 Gaz CH Rejection
August 22, 2022 2022/34 Gaz MX Rejection
August 19, 2022 2022/33 Gaz JP Rejection
July 18, 2022 2022/30 Gaz EM RAW: Rule 18ter(2)(i) GP following a provisional refusal
June 11, 2022 2022/24 Gaz GB RAW: Rule 18ter(2)(i) GP following a provisional refusal
June 2, 2022 2022/22 Gaz IL Rejection
May 24, 2022 2022/22 Gaz EM Rejection
May 16, 2022 2022/22 Gaz RAW: Limitation
April 21, 2022 2022/18 Gaz CN Rejection
April 20, 2022 2022/16 Gaz SG Rejection
April 9, 2022 2022/17 Gaz GB Rejection
March 25, 2022 2022/12 Gaz NZ Rejection
February 17, 2022 2022/8 Gaz CN Rejection
January 31, 2022 2022/5 Gaz RU Rejection
January 12, 2022 2022/2 Gaz AU Rejection
September 3, 2021 2021/40 Gaz US Registration

ID: 141621013